ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $43,000 | -2.3% | 1,025 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $44,000 | +2100.0% | 1,025 | +925.0% | 0.00% | – |
Q4 2018 | $2,000 | – | 100 | +270.4% | 0.00% | – |
Q3 2016 | $0 | – | 27 | 0.0% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 27 | -64.5% | 0.00% | – |
Q1 2016 | $2,000 | -33.3% | 76 | +4.1% | 0.00% | – |
Q4 2015 | $3,000 | 0.0% | 73 | -6.4% | 0.00% | – |
Q3 2015 | $3,000 | 0.0% | 78 | +9.9% | 0.00% | – |
Q2 2015 | $3,000 | +50.0% | 71 | -6.6% | 0.00% | – |
Q1 2015 | $2,000 | -33.3% | 76 | -29.0% | 0.00% | – |
Q4 2014 | $3,000 | – | 107 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |